NovaBridge Biosciences Depreciation
NovaBridge Biosciences (NBP) reported Depreciation of $68.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-04-07
- NovaBridge Biosciences depreciation for the quarter ending 2020-12-31 was 5.00M CNY, a 67.06% increase year-over-year.
- NovaBridge Biosciences depreciation for the quarter ending 2019-12-31 was 3.00M CNY.
CNY
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2023-12-31 | 23.95M CNY 20-F · filed 2024-04-30 | |||
| 2022-12-31 | 25.34M CNY 20-F · filed 2024-04-30 | |||
| 2022-06-30 | 12.20M CNY 6-K · filed 2022-11-10 | |||
| 2021-12-31 | 13.78M CNY 20-F · filed 2024-04-30 | |||
| 2021-06-30 | 6.73M CNY 6-K · filed 2022-11-10 | |||
| 2020-12-31 | 5.00M CNY derived: 20-F 12 month − 6-K 9 month · filed 2023-05-01 | 12.74M CNY 20-F · filed 2023-05-01 | ||
| 2020-09-30 | 7.74M CNY 6-K · filed 2021-02-05 | |||
| 2019-12-31 | 3.00M CNY derived: 20-F 12 month − 6-K 9 month · filed 2022-04-29 | 9.83M CNY 20-F · filed 2022-04-29 | ||
| 2019-09-30 | 6.83M CNY 6-K · filed 2021-02-05 | |||
| 2018-12-31 | 6.74M CNY 20-F · filed 2021-04-28 | |||
| 2017-12-31 | 1.63M CNY 20-F · filed 2020-04-29 |
USD
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $15.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | $32.00K derived: sum of 2 quarters · filed 2026-04-07 | $68.00K 20-F · filed 2026-04-07 | ||
| 2025-09-30 | $17.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18 | $53.00K 6-K · filed 2025-12-18 | |||
| 2025-06-30 | $36.00K 6-K · filed 2025-10-06 | ||||
| 2024-12-31 | $22.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | $42.00K derived: sum of 2 quarters · filed 2026-04-07 | $261.00K 20-F · filed 2026-04-07 | ||
| 2024-09-30 | $20.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18 | $239.00K 6-K · filed 2025-12-18 | |||
| 2024-06-30 | $219.00K 6-K · filed 2025-10-06 | ||||
| 2023-12-31 | $475.00K 20-F · filed 2026-04-07 | $3.37M 20-F · filed 2024-04-30 | |||
| 2022-12-31 | $206.00K 20-F · filed 2025-04-03 | $3.67M 20-F · filed 2023-05-01 | |||
| 2022-06-30 | $1.82M 6-K · filed 2022-11-10 | ||||
| 2021-12-31 | $2.16M 20-F · filed 2022-04-29 | ||||
| 2020-12-31 | $813.00K derived: 20-F 12 month − 6-K 9 month · filed 2021-04-28 | $1.95M 20-F · filed 2021-04-28 | |||
| 2020-09-30 | $1.14M 6-K · filed 2021-02-05 | ||||
| 2019-12-31 | $1.41M 20-F · filed 2020-04-29 |